Distinct domains of the mu-opioid receptor control uncoupling and internalization

Jeremy Celver1, Mei Xu, Wenzhen Jin

  • 1Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington 98195-7280, USA.

Molecular Pharmacology
|February 24, 2004
PubMed

Insights

Researchers identified a key region on the micro opioid receptor (muOR) crucial for uncoupling, a process distinct from receptor internalization, offering insights into opioid receptor desensitization.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Cell Biology

Background:

  • Homologous desensitization of micro opioid receptors (muOR) involves receptor uncoupling from G-proteins and internalization.
  • Understanding these distinct processes is vital for comprehending muOR regulation and signaling.

Purpose of the Study:

  • To resolve the distinct mechanisms of muOR desensitization, specifically uncoupling and internalization.
  • To identify the specific muOR domain responsible for agonist-dependent receptor uncoupling.

Main Methods:

  • Electrophysiological recordings (Kir3 channel activation) in Xenopus laevis oocytes and AtT20 cells.
  • Confocal microscopy for receptor localization.
  • Radioligand binding assays for cell surface receptor quantification.

Main Results:

  • Saturating agonist concentrations caused muOR internalization, while subsaturating concentrations induced uncoupling without internalization.
  • Threonine 180 in the muOR's second intracellular loop was essential for agonist-dependent uncoupling but not internalization.
  • Desensitization was confirmed as homologous, involving G protein-coupled receptor kinase (GRK) and arrestin pathways.

Conclusions:

  • Agonist-induced muOR uncoupling is mediated by GRK-dependent phosphorylation at Threonine 180.
  • MuOR internalization involves a separate GRK and arrestin-dependent mechanism.
  • These findings delineate specific molecular determinants for distinct muOR desensitization pathways.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Receptor-mediated Endocytosis01:20

Receptor-mediated Endocytosis

Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Receptor-mediated Endocytosis01:38

Receptor-mediated Endocytosis

Overview
Receptor-Mediated Endocytosis01:20

Receptor-Mediated Endocytosis

Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...